Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A Clearmind Medicine Inc. Filed by: Capitalink Ltd.

March 16, 2026 10:18 AM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: *Percentage calculated based on 2,088,806 common shares, no par value per share, of Clearmind Medicine Inc. (the "Issuer") issued and outstanding as of the reporting date, which amount was provided to the Reporting Person by the Issuer.


SCHEDULE 13G



Capitalink Ltd.
Signature:/s/ Lavi Krasney
Name/Title:Lavi Krasney/Chief Executive Officer
Date:03/16/2026

Categories

SEC Filings